Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer Drug to Substitute Aneurysm Surgery

Pfizer Drug to Substitute Aneurysm Surgery

27th June 2023

Aneurysms, which can be fatal, are enlarged, deteriorating brain arteries that affect around five in 100 individuals.

Only surgery can work to repair or remove brain aneurysms that are at danger of rupturing, and if the aneurysm is situated in a difficult-to-access area, surgery may not be an option.

However, recent research suggests that a cancer therapy called Sunitinib may be a potential alternative.

The medication has been marketed by Pfizer under the name Sutent, and during a study, seemed to stop mice from developing aneurysms.

Research lead, Hirofumi Nakatomi, explained that this “was a groundbreaking finding, opening the possibility to develop medications for aneurysms, which currently should be treated only by surgical methods.”

The scientists did not assess whether sunitinib could shrink or stabilise aneurysms that had previously developed, despite the fact that the results of using it were positive. This is something the team intend to look at in later investigations.

These medications be employed in the near future as a prophylactic measure for subsequent aneurysm development, which affects 10% of patients who have surgery.

Nakatomi said that they “anticipate that those drugs can be applicable relatively soon as preventive medications of recurrence of aneurysms after surgical treatments.”

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.